BUQUINOLATE
Buquinolate is an anticoccidial agent disrupting parasite metabolism. Used in veterinary applications. Side effects may include mild GI discomfort.
About MedicaPharma
MedicaPharma distributes high-quality active pharmaceutical ingredients (APIs) to hospitals, commercial (compounding) pharmacies, research institutes, and universities worldwide.
Network of over +400 GMP API producers
Let us handle your sourcing / supply activities. Highly experienced in sourcing specialty raw pharmaceutical ingredients from niche GMP manufacturers around the world.
Why Choose MedicaPharma
Niche API specialist - Pro-active supply partner - High service level - Global network - Logistics according to GDP regulations
Product Description
Mechanism of action
Buquinolate is a quinoline-derived antiprotozoal compound that disrupts mitochondrial electron transport in susceptible parasites. Its mechanism involves inhibition of electron flow at the cytochrome bc₁ complex, impairing oxidative phosphorylation and collapsing ATP production. This leads to parasite energy failure, membrane depolarisation, and eventual cell death. The compound may also exert secondary effects on folate-linked metabolic pathways often coupled to mitochondrial respiration in protozoa.
Benefits and advantages
Used in protozoal energy-metabolism research, mitochondrial electron-transport chain modelling, antimalarial and anticoccidial drug-development programmes, quinoline SAR studies and resistance-mechanism evaluations. Its defined mitochondrial target offers a clean system for studying bioenergetic collapse in parasites.
Side effects and risks
Risks include hepatic stress, mitochondrial toxicity at high doses, hypersensitivity and environmental persistence typical of some quinoline derivatives. Handle with antimicrobial and quinoline-compound precautions.
Datasheet
| Molecular Formula | C20H27NO5 |
|---|---|
| Molecular Weight | 361.4 g/mol |
| CAS Number | 1309823 |
| Storage Condition | Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light. |
| Solubility | Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance. |
| Purity | Purity information is available upon request (COA). |
| Synonym | BUQUINOLATE; 5486-03-3; Buquinolato; EU-1093; Buquinolatum |
| IUPAC/Chemical Name | ethyl 6,7-bis(2-methylpropoxy)-4-oxo-1H-quinoline-3-carboxylate |
| InChl Key | LVVXOXRUTDAKFE-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C20H27NO5/c1-6-24-20(23)15-9-21-16-8-18(26-11-13(4)5)17(25-10-12(2)3)7-14(16)19(15)22/h7-9,12-13H,6,10-11H2,1-5H3,(H,21,22) |
| References |
3D Conformer.
(Click, turn or enlarge)
Download our GMP API Product List.
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.



